Why do some cancer cells break away from a tumor and travel to distant parts of the body? A team of oncologists and engineers from the University of Michigan teamed up to help understand this crucial question.
In a major advance in precision medicine, an international collaboration of researchers found 90 percent of castration resistant metastatic prostate cancers harbored some kind of genetic anomaly that could drive treatment choices.
A new urine-based test improved prostate cancer detection – including detecting more aggressive forms of prostate cancer – compared to traditional models based on prostate serum antigen, or PSA, levels, a new study finds.
The American Cancer Society's estimates for brain and spinal cord tumors in the United States are for 2015. They include both adults and children.
About 22,850 malignant tumors of the brain or spinal cord (12,900 in males and 9,950 in females) will be diagnosed. These numbers would likely be much higher if benign tumors were also included.
Researchers have developed and tested a new tool that searches for the most common genetic anomalies seen in cancer. The assay demonstrates the ability to make gene sequencing easier over a large volume of samples. In the future, this may mean that patients would not always need to undergo a fresh biopsy in order to identify a potential treatment strategy, as is currently necessary with more comprehensive sequencing approaches.
At the University of Michigan Rogel Cancer Center, our Multiple Myeloma Program has a number of studies underway that are only available to our patients. We have extensive experience in selecting the right trial for each person.
Below is a list of some of the open trials. If you see one you may be eligible for or have questions, please call 800-865-1125 (Monday-Friday, 8am-5pm EST).
The sarcoma survivorship clinic is not seeing patients at this time. Please call our Cancer AnswerLine™ at 800-865-1125 for information on who can help you with your survivorship questions.
In certain types of cancer, nerves and cancer cells enter an often lethal and intricate waltz where cancer cells and nerves move toward one another and eventually engage in such a way that the cancer cells enter the nerves.
Most adrenal cancers have grown for a long time before they are diagnosed. They are often found after the patient seeks treatment for the symptoms caused by the cancer. However, some tumors are found when a physician orders imaging testing for another condition.
Patients with symptoms suspicious for adrenal cancer will undergo tests to determine the cause of these symptoms. The first step is a thorough medical history and physical exam to determine the extent of symptoms and their possible causes.
MENU